Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework

Strong evidence supports administration of magnesium sulphate prior to birth at less than 30 weeks' gestation to prevent very preterm babies dying or developing cerebral palsy. This study was undertaken as part of The WISH (Working to Improve Survival and Health for babies born very preterm) Pr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC Pregnancy and Childbirth 2015-08, Vol.15 (1), p.176, Article 176
Hauptverfasser:	Bain, Emily, Bubner, Tanya, Ashwood, Pat, Van Ryswyk, Emer, Simmonds, Lucy, Reid, Sally, Middleton, Philippa, Crowther, Caroline A
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Attitude of Health Personnel Babies Behavior Care and treatment Cerebral palsy Cerebral Palsy - prevention & control Children & youth Childrens health Clinical Competence Female Guideline Adherence - statistics & numerical data Health aspects Humans Infant, Extremely Premature Infant, Newborn Infant, Premature Infants (Premature) Magnesium Sulfate - therapeutic use Medical personnel Midwifery Midwives Neonatology Neuroprotective Agents - therapeutic use Obstetrics Patient outcomes Perinatal Death - prevention & control Practice Guidelines as Topic Pregnancy Premature Birth Qualitative research Reminder Systems South Australia Systematic review Time Factors Weight control Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!